{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:57:18Z","timestamp":1789689438857,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5942,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1093\/annonc\/mdg414","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T17:43:53Z","timestamp":1063993433000},"page":"1555-1561","source":"Crossref","is-referenced-by-count":92,"title":["Limited-stage mantle-cell lymphoma"],"prefix":"10.1016","volume":"14","author":[{"given":"H.A.","family":"Leitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chhanabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Klasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdg414_bb0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0020","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","article-title":"Mantle-cell lymphoma: a population-based clinical study","volume":"14","author":"Velders","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0030","first-page":"181","article-title":"Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse","volume":"113","author":"Swerdlow","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/mdg414_bb0035","series-title":"Jaffe ES","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"key":"10.1093\/annonc\/mdg414_bb0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","article-title":"Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group","volume":"64","author":"Weisenburger","year":"2000","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1093\/annonc\/mdg414_bb0045","first-page":"724a","article-title":"A subset of mantle cell lymphoma exhibits stable disease and correlates with mutated VH genes and low CD38 expression","volume":"98","author":"Garand","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0145-2126(99)00156-3","article-title":"Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation","volume":"24","author":"Laszlo","year":"2000","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/mdg414_bb0055","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/sj.leu.2401172","article-title":"Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas","volume":"12","author":"Pott","year":"1998","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdg414_bb0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdg414_bb0070","first-page":"993","article-title":"Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL)","volume":"83","author":"Callea","year":"1998","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdg414_bb0075","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","article-title":"Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants","volume":"15","author":"Majlis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0080","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","article-title":"European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL)","volume":"5","author":"Zucca","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0090","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma\u2014an entity comes of age","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mdg414_bb0095","first-page":"21","article-title":"Treatment of early stage Hodgkin\u2019s disease: improved outcome with brief chemotherapy and radiotherapy without staging laparotomy","volume":"7","author":"Klasa","year":"1999","journal-title":"Ann Oncol"},{"issue":"2 Suppl","key":"10.1093\/annonc\/mdg414_bb0100","doi-asserted-by":"crossref","first-page":"173a","DOI":"10.1016\/S0360-3016(97)80635-9","article-title":"Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I\u2013II Hodgkin\u2019s disease: six-year results of the EORTC-GPMC controlled clinical trials \u2018H7-VF\u2019, \u2018H7-F\u2019 and \u2018H7-U","volume":"39","author":"Noordijk","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10 Suppl 1","key":"10.1093\/annonc\/mdg414_bb0105","first-page":"485a","article-title":"Two cycles of ABVD plus radiotherapy is more effective than radiotherapy alone in early stage Hodgkin\u2019s disease\u2014interim analysis of the HD7 trial of the GHSG","volume":"94","author":"Tesch","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.1998.16.3.830","article-title":"Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin\u2019s disease: a meta-analysis of 23 randomized trials involving 3888 patients. International Hodgkin\u2019s Disease Collaborative Group","volume":"16","author":"Specht","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.20.1.197","article-title":"Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency","volume":"20","author":"Shenkier","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg414_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-107-1-25","article-title":"Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma","volume":"107","author":"Connors","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdg414_bb0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.1993.11.4.720","article-title":"Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin\u2019s lymphomas","volume":"11","author":"Tondini","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0135","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.1989.7.9.1295","article-title":"Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy","volume":"7","author":"Longo","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0140","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/1097-0142(19861015)58:8<1596::AID-CNCR2820580803>3.0.CO;2-G","article-title":"Stage I\u2013II follicular lymphoma. Treatment results for 76 patients","volume":"58","author":"McLaughlin","year":"1986","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0167-8140(84)80072-9","article-title":"Combined radiotherapy-chemotherapy for early stages non-Hodgkin\u2019s lymphoma: the 1975\u20131980 EORTC controlled lymphoma trial","volume":"2","author":"Carde","year":"1984","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00019606-199808000-00005","article-title":"Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas","volume":"7","author":"Fan","year":"1998","journal-title":"Diagn Mol Pathol"},{"key":"10.1093\/annonc\/mdg414_bb0155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg414_bb0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","article-title":"Mantle cell lymphoma: a retrospective study of 121 cases","volume":"12","author":"Samaha","year":"1998","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdg414_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0959-8049(01)00366-5","article-title":"A Danish population-based analysis of 105 mantle cell lymphoma patients incidences, clinical features, response, survival and prognostic factors","volume":"38","author":"Andersen","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0170","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg414_bb0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0360-3016(84)90028-2","article-title":"Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience","volume":"10","author":"Gospodarowicz","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdg414_bb0180","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/0277-5379(91)90425-D","article-title":"Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients","volume":"27","author":"Soubeyran","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0185","first-page":"783","article-title":"Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi","volume":"95","author":"Federico","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199309147362","article-title":"Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems","volume":"10","author":"Lopez-Guillermo","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdg414_bb0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0959-8049(97)10056-9","article-title":"Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients","volume":"34","author":"Oinonen","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.1997.4693273.x","article-title":"The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group","volume":"99","author":"Vandenberghe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdg414_bb0205","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1046\/j.1365-2141.1998.00907.x","article-title":"Blastic variant of mantle cell lymphoma shows a heterogeneous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes","volume":"102","author":"Pittaluga","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdg414_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s002770050545","article-title":"Management of mantle cell lymphoma","volume":"78","author":"Meusers","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdg414_bb0215","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdg414_bb0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","article-title":"Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study","volume":"25","author":"Decaudin","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdg414_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","article-title":"The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Stewart","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0230","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1702567","article-title":"Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation","volume":"26","author":"Martinez","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdg414_bb0240","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","article-title":"High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience","volume":"22","author":"Milpied","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdg414_bb0245","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood.V96.9.2934","article-title":"A phase I\/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas","volume":"96","author":"Press","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1093\/annonc\/mdg414_bb0250","first-page":"62","article-title":"Principles of radioimmunotherapy for hematologists and oncologists","volume":"27","author":"Press","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdg414_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/cbr.2000.15.15","article-title":"Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin\u2019s lymphoma (NHL): initial phase I\/II study results","volume":"15","author":"Weiden","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1093\/annonc\/mdg414_bb0260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00062752-199603060-00007","article-title":"The role of radioimmunotherapy in bone marrow transplantation","volume":"3","author":"Corcoran","year":"1996","journal-title":"Curr Opin Hematol"},{"issue":"4 Suppl","key":"10.1093\/annonc\/mdg414_bb0265","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/cncr.10307","article-title":"High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study","volume":"94","author":"Behr","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg414_bb0270","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V99.9.3158","article-title":"High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma","volume":"99","author":"Gopal","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1093\/annonc\/mdg414_bb0275","first-page":"334a","article-title":"evidence for need of upper and lower endoscopies with biopsy in staging of asymptomatic patients with aggressive mantle cell lymphoma (MCL)","volume":"96","author":"Romaguera","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg414_bb0280","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.11096","article-title":"Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma","volume":"97","author":"Romaguera","year":"2003","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/14\/10\/1555\/419740\/mdg414.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:16:38Z","timestamp":1582251398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419641888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0923753419641888"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdg414","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}